ADB-BUTINACA is classified being a artificial cannabinoid drug applied mainly in exploration to study its psychoactive Homes, receptor interactions, and probable therapeutic purposes. The powdered type of ADB-BUTINACA permits specific measurement and multipurpose software in experimental design,